T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
AGCO
AGCO
$7B
| $107M | 0.02% |
1,754,096
+422,609
| +32% | +$25.6M |
|
|
WBA
652
DELISTED
Walgreens Boots Alliance
WBA
| $106M | 0.02% |
1,459,449
-44,362
| -3% | -$3.01M |
|
|
AMRN
653
Amarin Corp
AMRN
$300M
| $106M | 0.02% |
326,340
+175,730
| +117% | +$13.3M |
|
654
Kosmos Energy
KOS
$1.48B
| $106M | 0.02% |
11,349,695
-1,473,825
| -11% | -$12.4M |
|
655
FTI Consulting
FCN
$4.16B
| $106M | 0.02% |
1,446,646
-21,111
| -1% | -$1.55M |
|
|
TSRO
656
DELISTED
TESARO, Inc.
TSRO
| $106M | 0.02% |
2,704,466
-378,881
| -12% | -$13.4M |
|
657
Ecolab
ECL
$77.2B
| $105M | 0.02% |
670,925
-10,704
| -2% | -$1.59M |
|
658
Adient
ADNT
$1.48B
| $105M | 0.02% |
2,666,201
-4,192,201
| -61% | -$189M |
|
659
Avient
AVNT
$4.2B
| $105M | 0.02% |
2,393,473
+42,213
| +2% | +$1.85M |
|
660
Fair Isaac
FICO
$22.8B
| $104M | 0.02% |
452,918
+5,685
| +1% | +$1.23M |
|
661
Safety Insurance
SAFT
$1.52B
| $103M | 0.02% |
1,153,052
-16,224
| -1% | -$1.5M |
|
|
PPBI
662
DELISTED
Pacific Premier Bancorp
PPBI
| $103M | 0.02% |
2,763,097
+6,710
| +0.2% | +$256K |
|
663
Gibraltar Industries
ROCK
$1.47B
| $103M | 0.02% |
2,253,750
+27,492
| +1% | +$1.19M |
|
664
Bloom Energy
BE
$70.5B
| $102M | 0.01% |
+3,000,536
| New | +$83.9M |
|
|
SGI
665
Somnigroup International
SGI
$13.7B
| $102M | 0.01% |
7,689,380
-80,800
| -1% | -$1.08M |
|
|
GTHX
666
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $102M | 0.01% |
1,941,412
+548,214
| +39% | +$29.9M |
|
667
Church & Dwight Co
CHD
$24.1B
| $101M | 0.01% |
1,703,112
-134,958
| -7% | -$7.64M |
|
|
PXD
668
DELISTED
Pioneer Natural Resource Co.
PXD
| $99.3M | 0.01% |
570,284
-5,811
| -1% | -$1.04M |
|
669
Twilio
TWLO
$38.6B
| $99.3M | 0.01% |
1,150,874
+837,569
| +267% | +$61.2M |
|
670
Hope Bancorp
HOPE
$1.84B
| $99.1M | 0.01% |
6,129,602
+15,249
| +0.2% | +$264K |
|
|
BSMX
671
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $98.9M | 0.01% |
12,743,024
-3,190,039
| -20% | -$25M |
|
672
Scholastic
SCHL
$785M
| $98.6M | 0.01% |
2,112,728
+118,159
| +6% | +$5.08M |
|
673
Elanco Animal Health
ELAN
$11.2B
| $98.3M | 0.01% |
+2,817,526
| New | +$99.1M |
|
674
Campbell Soup
CPB
$6.93B
| $98.3M | 0.01% |
2,682,258
-116,262
| -4% | -$4.74M |
|
675
Marriott Vacations Worldwide
VAC
$4.13B
| $97.7M | 0.01% |
874,048
+713,377
| +444% | +$84.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.